IL6 and COVID-19: The median serum IL-6 in the mild COVID-19 group was significantly lower (3.59 pg/mL [min–max of 1.50–638.30]) than that of the severe COVID-19 (28.82 pg/mL [min–max of 5.52–926.30], P <0.005).